< Back to latest news & events

Event

IQPC IP World Summit 2019 – Amsterdam

October 2019

Event date: 21st October 2019

HGF Partners Leythem Wall and Alexander Hagen will be attending IQPC IP World Summit in Amsterdam on 21-23 October.

IQPC IP World Summit is the premier global IP event filled with industry experts from the world’s leading industries. This event offers a mix of thought-provoking and practical sessions covering approaches to IP protection, strategy, and monetisation, including patents, brand protection, copyright, licensing and trade marks.

HGF Partner Leythem Wall will be speaking on day 1 and will be presenting ‘Early Certainty at the EPO and Board of Appeal Rule Changes – are we more certain’. The session will cover:

  • Statistical analysis of the EPO early certainty schemes
  • Overview and strategies in light of upcoming EPO Board of Appeal rule changes
  • Controlling the pace for patentees, and freedom to operate for third parties

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article